The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis

Kun Xu, Xuejun Tian, Sun Young Oh, Mohammad Movassaghi, Stephen P. Naber, Charlotte Kuperwasser, Rachel J. Buchsbaum

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: The tumor microenvironment has complex effects in cancer pathophysiology that are not fully understood. Most cancer therapies are directed against malignant cells specifically, leaving pro-malignant signals from the microenvironment unaddressed. Defining specific mechanisms by which the tumor microenvironment contributes to breast cancer metastasis may lead to new therapeutic approaches against advanced breast cancer. Methods: We use a novel method for manipulating three-dimensional mixed cell co-cultures, along with studies in mouse xenograft models of human breast cancer and a histologic study of human breast cancer samples, to investigate how breast cancer-associated fibroblasts affect the malignant behaviors of breast cancer cells. Results: Altering fibroblast Tiam1 expression induces changes in invasion, migration, epithelial-mesenchymal transition, and cancer stem cell characteristics in associated breast cancer cells. These changes are both dependent on fibroblast secretion of osteopontin and also long-lasting even after cancer cell dissociation from the fibroblasts, indicating a novel Tiam1-osteopontin pathway in breast cancer-associated fibroblasts. Notably, inhibition of fibroblast osteopontin with low doses of a novel small molecule prevents lung metastasis in a mouse model of human breast cancer metastasis. Moreover, fibroblast expression patterns of Tiam1 and osteopontin in human breast cancers show converse changes correlating with invasion, supporting the hypothesis that this pathway in tumor-associated fibroblasts regulates breast cancer invasiveness in human disease and is thus clinically relevant. Conclusions: These findings suggest a new therapeutic paradigm for preventing breast cancer metastasis. Pro-malignant signals from the tumor microenvironment with long-lasting effects on associated cancer cells may perpetuate the metastatic potential of developing cancers. Inhibition of these microenvironment signals represents a new therapeutic strategy against cancer metastasis that enables targeting of stromal cells with less genetic plasticity than associated cancer cells and opens new avenues for investigation of novel therapeutic targets and agents.

Original languageEnglish (US)
Article number14
JournalBreast Cancer Research
Volume18
Issue number1
DOIs
StatePublished - Jan 28 2016
Externally publishedYes

Fingerprint

Osteopontin
Fibroblasts
Breast Neoplasms
Neoplasm Metastasis
Tumor Microenvironment
Neoplasms
Therapeutics
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Stromal Cells
Coculture Techniques
Mesenchymal Stromal Cells
Heterografts
Cell Culture Techniques

Keywords

  • Agelastatin
  • Breast cancer
  • Cancer-associated fibroblast
  • Metastasis
  • Osteopontin
  • Tiam1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Xu, K., Tian, X., Oh, S. Y., Movassaghi, M., Naber, S. P., Kuperwasser, C., & Buchsbaum, R. J. (2016). The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Research, 18(1), [14]. https://doi.org/10.1186/s13058-016-0674-8

The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. / Xu, Kun; Tian, Xuejun; Oh, Sun Young; Movassaghi, Mohammad; Naber, Stephen P.; Kuperwasser, Charlotte; Buchsbaum, Rachel J.

In: Breast Cancer Research, Vol. 18, No. 1, 14, 28.01.2016.

Research output: Contribution to journalArticle

Xu, Kun ; Tian, Xuejun ; Oh, Sun Young ; Movassaghi, Mohammad ; Naber, Stephen P. ; Kuperwasser, Charlotte ; Buchsbaum, Rachel J. / The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. In: Breast Cancer Research. 2016 ; Vol. 18, No. 1.
@article{3cd47801a621497eb73e38616620312e,
title = "The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis",
abstract = "Background: The tumor microenvironment has complex effects in cancer pathophysiology that are not fully understood. Most cancer therapies are directed against malignant cells specifically, leaving pro-malignant signals from the microenvironment unaddressed. Defining specific mechanisms by which the tumor microenvironment contributes to breast cancer metastasis may lead to new therapeutic approaches against advanced breast cancer. Methods: We use a novel method for manipulating three-dimensional mixed cell co-cultures, along with studies in mouse xenograft models of human breast cancer and a histologic study of human breast cancer samples, to investigate how breast cancer-associated fibroblasts affect the malignant behaviors of breast cancer cells. Results: Altering fibroblast Tiam1 expression induces changes in invasion, migration, epithelial-mesenchymal transition, and cancer stem cell characteristics in associated breast cancer cells. These changes are both dependent on fibroblast secretion of osteopontin and also long-lasting even after cancer cell dissociation from the fibroblasts, indicating a novel Tiam1-osteopontin pathway in breast cancer-associated fibroblasts. Notably, inhibition of fibroblast osteopontin with low doses of a novel small molecule prevents lung metastasis in a mouse model of human breast cancer metastasis. Moreover, fibroblast expression patterns of Tiam1 and osteopontin in human breast cancers show converse changes correlating with invasion, supporting the hypothesis that this pathway in tumor-associated fibroblasts regulates breast cancer invasiveness in human disease and is thus clinically relevant. Conclusions: These findings suggest a new therapeutic paradigm for preventing breast cancer metastasis. Pro-malignant signals from the tumor microenvironment with long-lasting effects on associated cancer cells may perpetuate the metastatic potential of developing cancers. Inhibition of these microenvironment signals represents a new therapeutic strategy against cancer metastasis that enables targeting of stromal cells with less genetic plasticity than associated cancer cells and opens new avenues for investigation of novel therapeutic targets and agents.",
keywords = "Agelastatin, Breast cancer, Cancer-associated fibroblast, Metastasis, Osteopontin, Tiam1",
author = "Kun Xu and Xuejun Tian and Oh, {Sun Young} and Mohammad Movassaghi and Naber, {Stephen P.} and Charlotte Kuperwasser and Buchsbaum, {Rachel J.}",
year = "2016",
month = "1",
day = "28",
doi = "10.1186/s13058-016-0674-8",
language = "English (US)",
volume = "18",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis

AU - Xu, Kun

AU - Tian, Xuejun

AU - Oh, Sun Young

AU - Movassaghi, Mohammad

AU - Naber, Stephen P.

AU - Kuperwasser, Charlotte

AU - Buchsbaum, Rachel J.

PY - 2016/1/28

Y1 - 2016/1/28

N2 - Background: The tumor microenvironment has complex effects in cancer pathophysiology that are not fully understood. Most cancer therapies are directed against malignant cells specifically, leaving pro-malignant signals from the microenvironment unaddressed. Defining specific mechanisms by which the tumor microenvironment contributes to breast cancer metastasis may lead to new therapeutic approaches against advanced breast cancer. Methods: We use a novel method for manipulating three-dimensional mixed cell co-cultures, along with studies in mouse xenograft models of human breast cancer and a histologic study of human breast cancer samples, to investigate how breast cancer-associated fibroblasts affect the malignant behaviors of breast cancer cells. Results: Altering fibroblast Tiam1 expression induces changes in invasion, migration, epithelial-mesenchymal transition, and cancer stem cell characteristics in associated breast cancer cells. These changes are both dependent on fibroblast secretion of osteopontin and also long-lasting even after cancer cell dissociation from the fibroblasts, indicating a novel Tiam1-osteopontin pathway in breast cancer-associated fibroblasts. Notably, inhibition of fibroblast osteopontin with low doses of a novel small molecule prevents lung metastasis in a mouse model of human breast cancer metastasis. Moreover, fibroblast expression patterns of Tiam1 and osteopontin in human breast cancers show converse changes correlating with invasion, supporting the hypothesis that this pathway in tumor-associated fibroblasts regulates breast cancer invasiveness in human disease and is thus clinically relevant. Conclusions: These findings suggest a new therapeutic paradigm for preventing breast cancer metastasis. Pro-malignant signals from the tumor microenvironment with long-lasting effects on associated cancer cells may perpetuate the metastatic potential of developing cancers. Inhibition of these microenvironment signals represents a new therapeutic strategy against cancer metastasis that enables targeting of stromal cells with less genetic plasticity than associated cancer cells and opens new avenues for investigation of novel therapeutic targets and agents.

AB - Background: The tumor microenvironment has complex effects in cancer pathophysiology that are not fully understood. Most cancer therapies are directed against malignant cells specifically, leaving pro-malignant signals from the microenvironment unaddressed. Defining specific mechanisms by which the tumor microenvironment contributes to breast cancer metastasis may lead to new therapeutic approaches against advanced breast cancer. Methods: We use a novel method for manipulating three-dimensional mixed cell co-cultures, along with studies in mouse xenograft models of human breast cancer and a histologic study of human breast cancer samples, to investigate how breast cancer-associated fibroblasts affect the malignant behaviors of breast cancer cells. Results: Altering fibroblast Tiam1 expression induces changes in invasion, migration, epithelial-mesenchymal transition, and cancer stem cell characteristics in associated breast cancer cells. These changes are both dependent on fibroblast secretion of osteopontin and also long-lasting even after cancer cell dissociation from the fibroblasts, indicating a novel Tiam1-osteopontin pathway in breast cancer-associated fibroblasts. Notably, inhibition of fibroblast osteopontin with low doses of a novel small molecule prevents lung metastasis in a mouse model of human breast cancer metastasis. Moreover, fibroblast expression patterns of Tiam1 and osteopontin in human breast cancers show converse changes correlating with invasion, supporting the hypothesis that this pathway in tumor-associated fibroblasts regulates breast cancer invasiveness in human disease and is thus clinically relevant. Conclusions: These findings suggest a new therapeutic paradigm for preventing breast cancer metastasis. Pro-malignant signals from the tumor microenvironment with long-lasting effects on associated cancer cells may perpetuate the metastatic potential of developing cancers. Inhibition of these microenvironment signals represents a new therapeutic strategy against cancer metastasis that enables targeting of stromal cells with less genetic plasticity than associated cancer cells and opens new avenues for investigation of novel therapeutic targets and agents.

KW - Agelastatin

KW - Breast cancer

KW - Cancer-associated fibroblast

KW - Metastasis

KW - Osteopontin

KW - Tiam1

UR - http://www.scopus.com/inward/record.url?scp=84955476179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955476179&partnerID=8YFLogxK

U2 - 10.1186/s13058-016-0674-8

DO - 10.1186/s13058-016-0674-8

M3 - Article

VL - 18

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 1

M1 - 14

ER -